Omenn Gilbert S
SEC-identified person · CIK 1184227 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Amesite Inc. AMST | Director | filed 2020–2026 |
| PRO Pharmaceuticals INC prw | Director | filed 2014–2026 |
| Elicio Therapeutics, Inc. ELTX | Director | filed 2021–2022 |
| Amesite Inc. | Director | filed 2020–2020 |
| Esperion Therapeutics, Inc. ESPR | Director | filed 2014–2017 |
| Amgen INC AMGN | Director | filed 2006–2014 |
| Rohm & Haas CO ROH | Director | filed 2006–2009 |
| Tearlab Corp TEAR | Director | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.